23

2022-09


Minhai Biotechnology has been awarded the title of “National Model Enterprise for Building Harmonious Labor Relations.”

On September 19, 2022, the Ministry of Human Resources and Social Security, the All-China Federation of Trade Unions, the China Enterprise Confederation/China Entrepreneurs Association, and the All-China Federation of Industry and Commerce jointly issued the “Decision on Designating Model Enterprises and Industrial Parks for Building Harmonious Labor Relations Nationwide,” under which Minhai Bio was awarded the title of “National Model Enterprise for Building Harmonious Labor Relations.” On September 22, 2022, Zheng Haifa, the company’s general manager, delivered a presentation on behalf of the industrial park at the sub-venue of the district human resources and social security bureau. Mr. Zheng stated that, in recent years, Minhai Bio has thoroughly implemented the important instructions of General Secretary Xi Jinping on fostering harmonious labor relations and conscientiously carried out…

23

2022-09


The Party Branch of Minhai Biotechnology and the Party Branch of the Municipal Energy Conservation Inspection Brigade jointly organized a themed Party Day activity.

To further strengthen energy‑saving legal publicity, firmly establish the concept of green development, promote green and low‑carbon production and lifestyles, and support the goals of peaking carbon emissions and achieving carbon neutrality, on the afternoon of September 22, the Party Branch of the Municipal Energy Conservation Supervision Brigade visited the Party Branch of Minhai Bio to carry out an energy‑conservation awareness campaign. Wu Chengyu, Secretary of the Minhai Bio Party Branch; Li Guanghui, Deputy Secretary; Lu Kailang, Director of the Production and Operations Center; Zhang Yidi, Manager of the Safety and Environmental Protection Department; and other relevant leaders accompanied the visit and briefed the visiting officials on the company’s recent developments. On behalf of the company’s leadership, Secretary Wu extended a warm welcome to the leaders of the Municipal Energy Conservation Supervision Brigade. Manager Zhang then presented information to the municipal energy‑conservation supervision team…

26

2022-08


Minhai Biotechnology has been approved as a “Practical Training Site of the National Intellectual Property Administration Examiner Practice Base (Beijing Zhongguancun).”

Recently, Minhai Biotechnology was authorized by the National Intellectual Property Administration to become a “Practical Training Site of the National Intellectual Property Administration Examiner Practice Base (Beijing Zhongguancun).” The NIPA Examiner Practice Base is recommended by the Zhongguancun Intellectual Property Promotion Center and approved for establishment by the NIPA. Enterprises and institutions affiliated with this practice base undertake professional technical training, research, and internship activities for examiners. By organizing such practical initiatives, high-quality national examination resources can be precisely matched with innovation entities in Zhongguancun, thereby promoting the high‑quality development of corporate intellectual property. From August 8 to 12, the Pharmaceutical and Biological Examination Division of the National Intellectual Property Administration’s Bio…

22

2022-08


Leaders from the Biologics Division of the Pharmaceutical and Biological Products Review Department of the China National Intellectual Property Administration paid a visit to our company to conduct research and provide guidance.

On August 11, 2022, a delegation of leaders—including Inspector Pan Aiqun and Director Zhou Xia from the Biological Products Division of the Pharmaceutical and Biotechnology Invention Examination Department of the National Intellectual Property Administration—paid a visit to Minhai Bio to conduct on-site research and provide guidance. Deputy General Manager Mr. Huang received the visiting delegation. In the morning, a symposium titled “Vaccine Technology Innovation and Patent Work” was held in the company’s First Conference Room. Attending the meeting were Mr. Huang, Mr. Sun, all members of the Public Affairs and Research Management Departments, as well as project leaders and key researchers from the R&D Center. During the session, participants discussed issues arising in the patent application and examination processes related to technologies such as mRNA vaccines, multivalent combination vaccines, and novel adjuvants.

17

2022-08


Promoting the Jin Merchants’ Legacy and Traditional Culture to Drive Corporate Innovation and Development — A Team-Building Retreat for the Company’s Management Team

To further broaden managers’ perspectives, expand their thinking, and enhance their professional capabilities, enabling them to approach the second half of the year with greater enthusiasm and vigor, under the leadership of General Managers Miao, Zheng, and Liu, mid- and senior-level executives were dispatched in two groups—from August 5 to 7 and from August 12 to 14, 2022—to Shanxi Province to study traditional Chinese culture, explore the spirit of the Jin merchants, and discuss how enterprises can achieve sustainable development rooted in their own cultural foundations. During his inspection tour of Shanxi, General Secretary Xi Jinping emphasized, “Since ancient times, Shanxi has cherished a tradition of valuing commerce, giving rise to the Jin Merchant Spirit—characterized by honesty and trustworthiness, pioneering initiative, unity and mutual support, pragmatic management, and a commitment to benefiting society and the people.” The Jin merchants adhered to…

< 1...8910...31 >